ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000226.1|Gilvocarcin_1 # 1 # 2370 # -1 # ID=1_1;partial=10;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.765	BGC0000226.1|Gilvocarcin_1 	1	2370	-	Loose	400	28.8758	vanR gene in vanD cluster	35.71	3002923	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	TTGTCCGTTCGGTCACCCGGAAGGCAGTGGTGCGGCGTGACACGGCGCGGACTGCGGTTCGGACTGCTGGGAACACCGGTGCTGTACGACGGCGAGGGGCCCGACGCCCCCGGGTCCGTCCAGGTGACCGGAAGTCCCAAACTCCGTGCGCTGTTCGTCGCGTTGCTGCTCGACGCCGGGCGGGTCGTGTCCGTCGAGGCGCTGAAGGACGCCCTGTGGGGCGGTGCGCCGCCCGTCTCCGCGCTGCCCTCGCTGCACAATCACGTCGCCCGGTTGCGGCGGCTGCTCGACGACCCGGGCCGGCTGCTCACCGTGCCCACCGGATATCTGCTGCGGGTGGGAGAGGGCGAGGTGGACGTCCAGGTCTTCGACGCGCACACCGCAGCCGCCCGCGCCGCGCACACCGCCCGGGACTGGGAGCGGGTGGCGCGCGAGTGCGCCGCCGCGCTCGCGCTGTGGCGGGGGAACCCGCTGGCCGGGATGCCCCCGGAAGTGGGCGGCTACGCCCTGGTGCGGCGGCTGCGCGAGGCGCGGCTGCTGCTCCTGGAGTGGCGGTACGACGCCGAACTGGCCCTGGGCGGCGAGCGCCTGGCCGATCTCGTGCCCGAACTGGCGGCACTGGCCGCCGAACATCCGCTGCGGGAGTCGTACCACCGTCAGCTGATGCTCGCGCTGCACCGCACCGGCCGTCAGGCGGAGGCGCTGGTGGTCCACCGGGATCTGCGGGCCCGCCTGGCGGACGAACTCGGCGTCGAACCGGGGCCGGGGGTGCGCGAGGCCCACGTGGAGGTGCTGCGGGGGCAGGGGGAGCGGCAGGAGCACGGTCGGTGCGCGGAGGCCGCAGGAGGGGGCGGTGTGCCGCCCAGGCCGGCGCAACTGCCGCCCGCGCCTGCTCACTTCACCGGGCGGGACGCGGTGCGGGACGAGCTGATCCGTGTGCTCACCCGTGCCCCCCGGCCCGCCGCCGGGCCCCCTGCCGTCGTCGTCAGCGGTACCGCTGGTGTGGGGAAGAGCGCGCTCGCCGTCCAGGTCGCACACACACTGGCGGAACGTTTCGTCGACGGTCAGCTCTACGTCAACCTGCACGGCACGACCCCCGGCATGACCCCCCTCACCCCCGCCCAGGCCCTCAGCGCTCTCCTGCGCGACCTGGGCACCGAGCCCTGCGCCGTCCCCGAACGGCCGGACGCGGCCGCCGCCCTGCTGCGCTCGCTGCTCGCGCCCACCCGCACCCTCCTGGTGCTGGACGACGCCGCGGACGCCGCGCAGGTGCGGCCGCTGCTGCCGGGCGGACCCGGCTGTGCGGTGATCGTCACCAGCCGTTCGCCGCTCACCACGCTCGACGGTGCCGTCCGTGTCCCGCTCGGCCCGCTGTCCGACGAGGACAGTGCCGCCCTGCTGCGGGCGGTCTCCGGCCGGGACGGTCTCGGCGCCGGGCACCCGCTCGTCGCGCTCACCGGCCGGCTTCCGCTGGCCCTGCGGGTGGTCGCGGCCCGGCTCGCCGCGCGCCGGGCCCTCACGCCCGACGACCTCGCCGGTCAGCTCTCCGCCACCGACAGCCGGTTGCCGCACCTGGAGTACGACGACCTCAGCGTGCGCCGCTCGCTGGCCGTCGCGCACGACGCGCTCACCGTCTCCGACCGTGAGACGGACCGCGACGCCGCCCTCGCCCTGTGCCGCATCGGCGCGCTCGACCTGCCCGCCTACGGCGCGCCGCTGCTCGCCCGGCTCACCGGCACCGGCGAACGCCGGGCGGAGGCCGCGCTGGACCGGCTCGTCGACGTGGCCCTCGTGGAGGAGACCGCGTACGGCCGCTACGTCCCCCACGACCTGGTCCGTGACTTCGCCCGCGAACGAGCCCGAGCGGCGGCGGGTCCGCAGACCGCGCCCCGCGAGGACGCCGCACTCCGCGAGGACGCCGTACTCCGCGAGGATGCCGTACTCCGCGAGGATGCCGTACTCCGCGAGGGCGCCGTACTCCGCGAGGGCGCCGTACTCCGCGAGGGCGCCGTACTCCGCGAGGGCGCCGCACCCCGCGAGGGCGCCGCACCCCGCGAGGAGGCCGTACTCCGCGAGGATGCCGCACCCCGCGAGGACGCCGCACCCCGCGAGGACGCCGGCCCTCGGACCGGCACGCGCGAGCACCCCGCCGAGACCGCCCTGCGCTGGTACGCCGCCGTCGCCGAACGCGCCCTCACCGCGATCGTCGAACCCGGCCCCGACCAGGACGACCGCCGCCGCCCGACCCCGTCCCAGCCGCCCGGGCACACCGCTCACGTCGCGTCCGTACCCCCGTTCGACGACGCGGGGGCGGCCTTCGCCTGGGGCGACCGGGAGCTGGAGAACATCGTCACCCTCGTCGGGCGGTAC	MSVRSPGRQWCGVTRRGLRFGLLGTPVLYDGEGPDAPGSVQVTGSPKLRALFVALLLDAGRVVSVEALKDALWGGAPPVSALPSLHNHVARLRRLLDDPGRLLTVPTGYLLRVGEGEVDVQVFDAHTAAARAAHTARDWERVARECAAALALWRGNPLAGMPPEVGGYALVRRLREARLLLLEWRYDAELALGGERLADLVPELAALAAEHPLRESYHRQLMLALHRTGRQAEALVVHRDLRARLADELGVEPGPGVREAHVEVLRGQGERQEHGRCAEAAGGGGVPPRPAQLPPAPAHFTGRDAVRDELIRVLTRAPRPAAGPPAVVVSGTAGVGKSALAVQVAHTLAERFVDGQLYVNLHGTTPGMTPLTPAQALSALLRDLGTEPCAVPERPDAAAALLRSLLAPTRTLLVLDDAADAAQVRPLLPGGPGCAVIVTSRSPLTTLDGAVRVPLGPLSDEDSAALLRAVSGRDGLGAGHPLVALTGRLPLALRVVAARLAARRALTPDDLAGQLSATDSRLPHLEYDDLSVRRSLAVAHDALTVSDRETDRDAALALCRIGALDLPAYGAPLLARLTGTGERRAEAALDRLVDVALVEETAYGRYVPHDLVRDFARERARAAAGPQTAPREDAALREDAVLREDAVLREDAVLREGAVLREGAVLREGAVLREGAAPREGAAPREEAVLREDAAPREDAAPREDAGPRTGTREHPAETALRWYAAVAERALTAIVEPGPDQDDRRRPTPSQPPGHTAHVASVPPFDDAGAAFAWGDRELENIVTLVGRY	MNEKILVVDDEKELADLVEVYLKNDGYTVYKFYNGRDALNCIESVELDLAILDIMLPDIDGFQICQKIREKFYFPVIMLTAKVEDGDKIMGLSVADDYITKPFNPLEVVARVKAQLRQYMRYKQPCIKQEAERTEYDIRGMTISKSSHKCILFGKEIQLTPTEFSILWYLCERQGTVVSTEELFEAVWGERYFDSNNTVMAHIGRLREKMKEPSRNPKFIKTVWGVGYTIEK	340.52	gnl|BL_ORD_ID|1052|hsp_num:0	1004			522	645	vancomycin; teicoplanin
BGC0000226.1|Gilvocarcin_2 # 2571 # 3482 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.738	BGC0000226.1|Gilvocarcin_2 	2571	3482	-	Loose	200	27.335	vanX gene in vanO cluster	41.67	3002954	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanX; glycopeptide resistance gene cluster	GTGGAGTGGGGTGAGGGCATGGGGACGCCGAGGATCGCCGTCGCCGTCGTGACCATGGGGAACCGGCCGGCCGAGGTGGACGCGCTGCTGGAGTCCGTGGCGAAGCAGGACGTGGCGCCCGCGCGGATCGTGATCGTGGGGAACGGCTGTCCGCTGCCCGAGTTCGCCCGGCGGCTGTCCCTGCCCGGTGAGGTCACCACCGTCGAGCTGGCGGAGAACCTCGGCTGCCCGGGCGGGCGGAACGTGGGGATCGAGCGGCTGCGGGAGTTCGGGGACGTGGACGTCGTCGTCGAACTGGACGACGACGGTCTGCTGGTGGACGCCGATGTGCTGCGCCGGGTGGGGGAGTTGTACGCGGCGGACGACCGGCTCGGCGTCGTCGGCTTCCGGATCGCCGACGAGCTGGGGGAGACGCAGCAGCGGCACGTGCCCCGGCTCGGAAAGGCGGACCCGATGAAGGGCGGGTACGTCACCGGGTTCCTCGGGGGCGGGCACGCGCTGCGGATGTCGATGCTCGACGAGATCGGCGACTGGCCCGGCGCGTTCTTCTTCGCGCACGAGGAGACCGACCTCGCCTGGCGTGCCGCCGACGCGGGGTGGCGCATCCTCTACGCGCCCGACCTGCTGCTCCAGCACCCCAAGACCTCGCCGGCCCGGCACGCGATCTACTTCCGGGTGAACGCCCGCAACCGGGTCTGGCTGGCCCGGCGGCGGCTGCCGCTCGCGCTGATCCCCGTGCACCTCGGGGTGTGGGTCCTGCTCACCCTGCTGCGGACTCGGTCGGTCCAGGGGCTGCGCGCCTGGTTCGGCGGTTTCGCGGAGGGGCTGCGGGAGCCGGCCGGGGAGCGGCGGGCCATGCGCTGGCGGACGGTGTGGCGGCTCACCCGGCTCGGACGGCCGCCCGTCATCTGA	MEWGEGMGTPRIAVAVVTMGNRPAEVDALLESVAKQDVAPARIVIVGNGCPLPEFARRLSLPGEVTTVELAENLGCPGGRNVGIERLREFGDVDVVVELDDDGLLVDADVLRRVGELYAADDRLGVVGFRIADELGETQQRHVPRLGKADPMKGGYVTGFLGGGHALRMSMLDEIGDWPGAFFFAHEETDLAWRAADAGWRILYAPDLLLQHPKTSPARHAIYFRVNARNRVWLARRRLPLALIPVHLGVWVLLTLLRTRSVQGLRAWFGGFAEGLREPAGERRAMRWRTVWRLTRLGRPPVI	MNDDFVYVDDWVPGVRWDAKYATWDNFTGKPVDGYLANRIVGTRALCAALEQAREKAASLGFGLLLWDGYRPRRAVDSFLRWSEQPEDGQTKQRHYPNIDRPEMLEKGYVATQSGHSRGGAVDLTLYHLATGELAPMGGDHDLMDPISHHRARGIKPIESKNRELLRSIMEDCGFDRYDCEWWHYTLKREPYPDVYFDFPIT	150.00	gnl|BL_ORD_ID|1672|hsp_num:0	1699			258	330	vancomycin
BGC0000226.1|Gilvocarcin_3 # 3680 # 4357 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GCACG;rbs_spacer=15bp;gc_cont=0.720	BGC0000226.1|Gilvocarcin_3 	3680	4357	-	Loose	200	26.5646	ANT(3'')-IIc	29.07	3004091	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGCGTCCGTACATCGTCCGCGCATCGTCTGGAGACGGCATGAAAGTAGCAGTGCTCGGTGCAAGCGGCCCGACCGGACGGCAGGTGACGGCCCTGGCCTGTGCGGCCGGCCATGACGTCGTCGCCGTCGTCCGGCGTCCGGGTTCGGTCACTCCGGGGGAGAGGCTGACCGTGGAAACGGCGGACGTCACGGACGTCGCGGACATGACGTCCGTGTTCAAGGGCGCCGACGCCGTCCTGTCCTGCCTGGGAGCGCCGTACTCCTGGAGGCCGGTCACGGTCTACTCGGCGTCCGCCCGGGCCGTCGTGGACGGGATGCGCGCGGCGGACGTCAGGCGCCTGGTCGTCGTGAGCGCCGGCCTGACACATCCGGTCACCCGGGGCGGGGTGCGATGGCAGCGGCCGGTCTACGGCATCCTGCGCAACGGCCCCGGGCGGACCCTGTACGCGGACATGCGCCGCATGGAGGACATCCTCACCGGAGCCCGCGACCTGGAGTGGACGGTCATGCGTCCCGCCCGGCTCAGCGACGAGGCACGCCCGGGCGACGAGCTGCGGGTCACCGCCGACCTTCCCGGCGGACGGGCATGGACGACGCGCCGCGACCTCGCGATCGCCATGCTCGACGAACTCACCACCCCGCACACGCACCAGAGCCCCTTCGTCACCACCCGCTGA	MRPYIVRASSGDGMKVAVLGASGPTGRQVTALACAAGHDVVAVVRRPGSVTPGERLTVETADVTDVADMTSVFKGADAVLSCLGAPYSWRPVTVYSASARAVVDGMRAADVRRLVVVSAGLTHPVTRGGVRWQRPVYGILRNGPGRTLYADMRRMEDILTGARDLEWTVMRPARLSDEARPGDELRVTADLPGGRAWTTRRDLAIAMLDELTTPHTHQSPFVTTR	MSETLQLEQLTGYLQQLLGESLFAIYLYGSAVDGGLGPESDLDILVVVSQALTLPQRQQLAETLLQISHPIGAAQRALEVTIVRKDHILSGSYPLSYELQFGEWLRDELSQGDMLSEHADPDLSILLKKAQLHHRSLFGPSLTQWSVEIPDQQLWQAMADTYPSIVAHWDEDADERNQILALCRIYFSLVTNEIAPKDQAAQWVIAQLQPQHQPVLQRMVQEYKGEIEKQNWQQQHHALQPVVDFLSSKIDERFKQKKV	86.87	gnl|BL_ORD_ID|2357|hsp_num:0	2755			117	360	spectinomycin; streptomycin
BGC0000226.1|Gilvocarcin_5 # 4839 # 6035 # -1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=CGCGCG;rbs_spacer=14bp;gc_cont=0.693	BGC0000226.1|Gilvocarcin_5 	4839	6035	-	Loose	700	27.335	FOX-2	29.73	3002156	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	FOX beta-lactamase	GTGATCTCCACATCGACGATCCCCCACCTCGATCTCGATCCGTACACGGACGCGTCGATAACCGACCCGTACCCCCTGTACGGTGCGCTGCGCGACGCGGCACCGGTGGTGTACCTGACGGCGCACCAGGTGCACTGCGCCGCCCGCTACGACGAGGTGTACGCGGCCCTGCACCGCCACGGCACGTTCGTGTCCGGCGAGGGCGTCGGTCTGACCGACACCCTGAACAAGGCGCAGAAGGGCAGTAGCTTCACCAGCGACCCGCCGTACCACGCCTACGTGCGGGGGCTCGTGGCCCGCCACCTGAAGCCCCGCGCGATGGCCGACATCAACGGGTACGTCACGTCCTGGGCGGACCGTCTTGTCCGGGACCTCGTCGCCCGGAAGTCGTTCGACGCCGTCCAGGACTTCGCGGTCGCCTTCCCGCTGGCCGTGGTGCCCGATCTGCTGGGATGGCCGGAGGGCGAGGGGAAGGAAAGGCTCCTGGAGTGGGCCAGCGCCGGATTCAACGCCTTCGGTCCCCTGAACGACCGGACGCGGGCCGGCCTGCCGCTGCTCGGCGAGATGGGCGAGTTCCTCCACCGGATGTCACAGCCCGGCAATCTGCGTCCGGGGAGCTGGGGTGCCGAACTCGTCTCGGAGGCCCGCGAGGGCAAGATCGAGGACAAGCTGCTGCCCGGACTGCTCGGTGACTTCCTCGCCCCGTCCATGGACACGTCCGTCAGCGCGCTCTCCAGCATGCTGTGGCTGCTCGGCACGCACCAGGACCAGTGGCGCCGTCTGCGGGAGGACCCCTCCCTGGTCTCGTCGGCCTTCAACGAGATCATCCGGCTGGAATCGCCGCTGCGCGGGTTCACCCGCTACGTCGCCGAGGACACGGAGCTGGGCGGAGCCGCGCTGCCCCGCGGATCGCGCGTCCTCCTCCTCTTCGGTTCGGCCAACCGTGACGAGCGGTTCTGGAAGGACCCGGAGTCCTTCGACGTCGCCCGGCAGGGCGCGGCCCAGCACGTCGGTTTCGGGCACGGTATCCACGCCTGCGTCGGTCAGGCCCTGTCCCGCCTGGAGGGGCAGAGCCTCCTGGAGGCGCTGGTCCGTCACGTCGACAGGATCGAGGTGGGGGAGCCGACCTGGAGGCTGCACAACACCATCCGCGGGATCGAGAGGATGGATGTGACGTTCCATGGACGAACTGCCTGA	MISTSTIPHLDLDPYTDASITDPYPLYGALRDAAPVVYLTAHQVHCAARYDEVYAALHRHGTFVSGEGVGLTDTLNKAQKGSSFTSDPPYHAYVRGLVARHLKPRAMADINGYVTSWADRLVRDLVARKSFDAVQDFAVAFPLAVVPDLLGWPEGEGKERLLEWASAGFNAFGPLNDRTRAGLPLLGEMGEFLHRMSQPGNLRPGSWGAELVSEAREGKIEDKLLPGLLGDFLAPSMDTSVSALSSMLWLLGTHQDQWRRLREDPSLVSSAFNEIIRLESPLRGFTRYVAEDTELGGAALPRGSRVLLLFGSANRDERFWKDPESFDVARQGAAQHVGFGHGIHACVGQALSRLEGQSLLEALVRHVDRIEVGEPTWRLHNTIRGIERMDVTFHGRTA	MQQRRALALLTLGSLLLAPCTYASGEAPLTAAVDGIIQPMLKEYRIPGMAVAVLKDGKAHYFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSHHAPWLKGSAFDGVTMAELATYSAGGLPLQFPDEVDSNDKMQTYYRSWSPVYPAGTHRQYSNPSIGLFGHLAANSLGQPFEKLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPIRVTPGVLAAEAYGIKTGSADLLKFVEANMGYQGDAALKSAIALTHTGFYSVGDMTQGLGWESYAYPVTEQALLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLANRNYPIEARVKAAHAILSQLAE	104.19	gnl|BL_ORD_ID|702|hsp_num:0	764			468	684	
BGC0000226.1|Gilvocarcin_6 # 6040 # 7179 # -1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.704	BGC0000226.1|Gilvocarcin_6 	6040	7179	-	Loose	700	41.5874	mgtA	28.57	3000462	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	mgt macrolide glycotransferase	GTGAAGGCCCTCTTCTACGCCGCGGGCACGAGCCCGGCCAGCGCGTTCGCCATCGGACCCCTCGCCTCGGCACTCCGGTTGTCCGGGCACGACGTCCTGGTGGCGTCCTTCGAGGAGATGTCCGGCGCCGTCACCGGCATCGGTCTGCCGTCCCTCCCGGTGGCCCGGGGGCACACGACCGAGAGCATCAAGGCGGCCGCCGGCGGCAAGCCGGCGATCGAGTACCCCCACCGGCCCGAACAGGAGATGCCCTACCTGGGCCACTGGTTCGGGCGTCAGGGAAGCCACGTCTTCGACGACCTGGTGGACGTCGCCCGGACGTGGGGCGCCGACGTCCTGATCGCGGGGAGCCAGGGACACGGTGCCGAGATCGCCGCCCGGTTCCTCGGCATCCCCTTCGTCCGGCAGTCCTGGGACCTGTTCGACGTCGGCGGCTACGAGGAGTACCTCCTCGAGGAGATGGCGGACGAGCTGGCCAGGATCGGCTCGGACGCACTGCCCGACCCCTCACTGAAGATCGACATCTGCCCGCCCGGCCTGGTCGGGGCGACCGGCACCTTCATGCGCTGGACCCCGCACAACATGCAGCGGGCGATCGAGCCGTGGATGCTGACGGCTCCGGACGCCGGGCGCGTGTGCCTGACGATGGGAAGCTTCCGGTACGCCTTCCCCGGCGCGATGGACCGCATCTCGGCCATCGTCGAAGGGCTGCTGGAGCTCGAGGTCGAGGTCGTCGTGGCCATCGGCGAGGCGGAGGGGCAGCGGCTGCAGGAGAAGTACCCCCGGGTGCGCGCCGGCTGGATCCCGCTGGAGGCCATCCTCCCGACCTGTGAGGTGATCATCCATCCGGCGGGCGGACTGACGGCCATCAACGCCATCAACACGGCGACTCCGCAGCTGATCCTCAACCCCTTCGAGGCCTTCGTCCCGAGGCTGAAGCACCTCACGGACTACGGGTGCGCGCGGACGCTCTACCGCGAGGAGGGCACCCCGGAGGCGATCACGCAGGTGGTCAAGGAGATGCTCGGGGATCCGTCCTACTCCTCCAGGGCCCGGAGACTGGCGGAGCAGGGCGCGACCGCGCCGACGGCCGTGGGCATGGTGCCGCTGATCGAAGACCTCCTCGCGCGGAAAGGATGA	MKALFYAAGTSPASAFAIGPLASALRLSGHDVLVASFEEMSGAVTGIGLPSLPVARGHTTESIKAAAGGKPAIEYPHRPEQEMPYLGHWFGRQGSHVFDDLVDVARTWGADVLIAGSQGHGAEIAARFLGIPFVRQSWDLFDVGGYEEYLLEEMADELARIGSDALPDPSLKIDICPPGLVGATGTFMRWTPHNMQRAIEPWMLTAPDAGRVCLTMGSFRYAFPGAMDRISAIVEGLLELEVEVVVAIGEAEGQRLQEKYPRVRAGWIPLEAILPTCEVIIHPAGGLTAINAINTATPQLILNPFEAFVPRLKHLTDYGCARTLYREEGTPEAITQVVKEMLGDPSYSSRARRLAEQGATAPTAVGMVPLIEDLLARKG	MKRKELHETSRLAYGRRMTTRPAHIAMFSIALHGHVNPSLEVIRELVARGHRVTYAIPPLLADKVAEAGAEPKLWNSTLPGPDADPEAWGSTLLDNVEPFLADAIQSLPQLAQAYEGDEPDLVLHDIASYTARVLGRRWEVPVISLSPCMVAWEGYEQEVGEPMWEEPRKTERGQAYYARFHAWLEENGITDHPDPFIGRPDRSLVLIPKALQPHADRVDETTYTFVGACQGDRTAEGDWARPEGAEKVVLVSLGSAFTKQPAFYRECVRAFGELPGWHTVLQVGRHVDPAELGDVPDNVEVRTWVPQLAILQQADLFVTHAGAGGSQEGLATATPMIAVPQAADQFGNADMLQGLGVARTLPTEEATAKALRTAALALVDDPEVAARLKEIQARMAQEGGTRRAADLIEAELAAARG	90.67	gnl|BL_ORD_ID|2293|hsp_num:0	515			912	1206	erythromycin; tylosin; azithromycin; methymycin
BGC0000226.1|Gilvocarcin_7 # 7176 # 7526 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=CCCG;rbs_spacer=15bp;gc_cont=0.638	BGC0000226.1|Gilvocarcin_7 	7176	7526	-	Loose	400	23.483	ErmW	40.91	3001306	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAAGTTCGCCGCCGTCCTTGTCGTCAACTACCTCACCCCGTGGTACGAGTTGTCCCTCGACGAGCGCATCACGGTCGAACACGAGCACGTCTTCCCCAGCATCGGCGCCTTCGTGAAGCGGGGCGGGGAGATAACACCGGTGCGCGCCATCAAGTACGGCCGTGAGGCGGAGAGTTTCTTCATCCTGGGCTTCGACGAGATGGACAACTACCTGGACCTGGTCCGGGAGCTGCGTTCGAGTCGTCTGCTGACCTCGGGCCTCGCCGTCATCGACTTCGAGACCGTGGGCCTGAAGGAGGCCTACTTCGCGGAACGCGACAAGGACCGGTCACGGGAGGGCGCCGCGTGA	MKFAAVLVVNYLTPWYELSLDERITVEHEHVFPSIGAFVKRGGEITPVRAIKYGREAESFFILGFDEMDNYLDLVRELRSSRLLTSGLAVIDFETVGLKEAYFAERDKDRSREGAA	MSSIRRRHAAASLDTPAVGGRHELGQNFLVDRGVCTRIAEVVSSTTAHPVLELGAGDGAITRALVAANLPVTALELDPRRVRRLQRTFADGVTVVHGDMLRYDFGPYPHHVVSTVPFSITTPLLRRLIGQRFWHTAVLLVQWEVARKRAGVGGTTMLTAASWPWYEFTLVERVPKTSFDPVPSVDGGILVIERRSAPLLDDRCVGDYQNLVREVYTGPGRGLAAILRTRLPGREVDAWLRRERVDPAALPRDLKAGHWASLYRLYREVGTRPAPAGRSVRARPGSVGPDRSLPPRGLRSGPPRARRRGGGA	37.30	gnl|BL_ORD_ID|1572|hsp_num:0	1714			486	552	erythromycin; josamycin
BGC0000226.1|Gilvocarcin_8 # 7523 # 8266 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.692	BGC0000226.1|Gilvocarcin_8 	7523	8266	-	Loose	450	30.4166	rmtG	36.25	3002668	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGCCAACGGGCAGCACGGAGAAGATCCCCTTCGAGAAGCTCTACCAGGACGGGGAGAAGTCAGGCCCCCTCATGCCGTGGAACATCGGCGGCCCGCAGCCGGCCGTACGCGCGATCTGTGATCGCGGCGGCTTCCGCGGGCACGTGCTCGATCTGGGCTGCGGGCTCGGAGACAACGCGCTCTACCTGGCTTCCCGGGGGCTGCGGGTCTCCGCGGTCGACATCTCGGAGGTCGCCGTCCAGTGCGGGCGCGACAAGGCCCGGGACCACGGCGTGAGCGTCGACTTCCAGGTGACCGACGCCTTCCGCCTCGCGGAGTCCGGTGTCCGGTACGACGCCGTCCTGGACAGCGCCTTCTTCCACACGCTGCCGCAGGAGGAGGTGCCGCGCTACACGGAGCTCCTGCGGACCCTGTGCAAGGAGGGGGCCGAGCTGCACCTGTTCACCTTCTCGAAGGAGCTGACCCCCGACTACCCGGGTCCGCGCCGCATCTCCGAACCGGAGTTGCGGGAGGCGTTCGGCGCCGACTGGGACATCAAGGTGATCGAGGCGACGCGGTACCACAGCTCGCTGCCGCCGGAGGCCGTCGCGCAGATGGTCGACCCGCGGACCTTCGAGGTGAACGCCCCCACCGACAACCTCGCCGCCCAGATGGTGGACGAAGCCGGGAACGTCGTCTCCCACATCTGGCACATGCATGCCGTACTGCGTCCGCAGGCAACCCGATCGGAGAGCCCGGCATGA	MPTGSTEKIPFEKLYQDGEKSGPLMPWNIGGPQPAVRAICDRGGFRGHVLDLGCGLGDNALYLASRGLRVSAVDISEVAVQCGRDKARDHGVSVDFQVTDAFRLAESGVRYDAVLDSAFFHTLPQEEVPRYTELLRTLCKEGAELHLFTFSKELTPDYPGPRRISEPELREAFGADWDIKVIEATRYHSSLPPEAVAQMVDPRTFEVNAPTDNLAAQMVDEAGNVVSHIWHMHAVLRPQATRSESPA	MRDPLFEKLAASKKYRDVCPDTIARILTECRAKYRREKEIDKAAREKLHGITAAFMTDAEYRRAMEIAVRGGELAELMECHASTRERLPLEETDAVYARLLGAPDESALDLACGLNPAYLQNRYPEMRVTGIDISGQCVRVLRALGVDARLGDLLAENAIPRARYSVALLFKILPLLDRQSAGAARRILEAVNADALICSFPTRSLSGRNVGMAVHYAAWMRDQLPEKWRIERTVETDNELYYVLKEKQDGEAVRGGDSHRESE	93.56	gnl|BL_ORD_ID|1266|hsp_num:0	1382			324	525	amikacin; tobramycin; arbekacin; gentamicin A; gentamicin
BGC0000226.1|Gilvocarcin_9 # 8282 # 9778 # -1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.705	BGC0000226.1|Gilvocarcin_9 	8282	9778	-	Loose	550	29.261	PmrF	32.43	3003578	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	GTGACCGCTTCCGTACCGCCGTTCACGGTGGGCCGCGAGGACCCGCGGTACATCGAACTGTCGCACTCGGACAACCACCGGTTCGTCGTCGAGCCCGAGGAGTTCTTCCTCCCCGCCACGCCGGACGACGTCGTCGCCTCCCTGCAGAAGGCCGTCACGGAAGGGCGGGGGGTCGCCTGCCGGTCCGGCGGTCACTGCGGCCAGGACTTCGTCGGCACGCCGCGCCGGGACCTCGTCCTGGACCTGCACAACCTCCATGCCATCGGCCCGGCCGCGGACGGCGCCGGGGTGCGCGTCGGTTCCGGTGCGACGGTCGACCAGGTCCAGAAGGCCCTGTTCCGCCGGTGGAACGCGGCCCTGCCGCTCGGGGCCTGCTCCGCGGTCGGCATGGGCGGCCTGGTCGCCGGAGGTGGTTACGGGCCGCTGTCGCGCCAGCTGGGGCTGGTGGTCGACCACCTGCACGCGGTGGAGGTCGCCGTCGTCGACGAGTCCCGCACCGTTCGCCTCGTGACGGCGAGGGCCGACGACACCGGCGATCTCGGTGAGCTCTTCTGGGCACACACCGGCGGTGGCGGCGGCAACTTCGGCGTGGTCACGGCGTACGAGTTCCGCAGCCCGGAGCACCTCGCCACGGAACCCGTCGGCCTGCCCCGCGCCGCCGGCCGACTGCACGTCCAGAAGGTGGTGTTCCCCTGGGCCATGATCGACGAGACGTCCTTCGTCACTGTGATGAGACGTTTCTTCGAGTGGCATGAACGCCACTCCGAGCCGGGGTCGCCGGAGTCCTCGCTGTTCGCCACCTTCTTCGTGAACCACGTCAGCTCGGGCGTCCTGCAGCTGATGGTCCAGCAGGACGCCGACGTGGACCCCGAGGGCGAGATCCTCGCGCGGTTCGTCGCGTCCCTGACCGAGGGCACCGGCGTGGTGGGCATCCCCCGAGGGGGTGTCATGAGCTGGCTCACCGGAACCCGCTACATGAGTCAGGCCGACTGCGGTGACGTCATGGGCGCCCGCTCCGCCTCCAAGTCCGCCTACCACCGCGCGGCACCCACCGACGAGCAGCTCTCGGTGCTCCACCGGCACCTGCACGCCGACCACCCCGGCCAGGCCTCGTACGTCATGTTCAACAGCTACGGGGGAGAGATCAACCGGCGGGGGCCGTCGGACGCCGCCGTCCCCCAGCGGGACTCCGTCGTGAAGTCGTCCTGGTTCTCGGCCTGGCAGGACGCGGAGCTGGACGAGCTGCACCTCGGCTGGCTGCGCGGGCTCTACGAGGAGTTCTTCGCCGGCACGGGAGGGGTGCCCGTCACCGGCGGCCGCACGGACGGCTGCTACATCAACTACCCCGACGCGGATCTCCTGGACCCGGCCCGCAACCGCTCCGGGGAGCCCTGGCACCACCTGTACTACAAGGACAACTACGCCCGTCTGCGGTCGGCGAAGCGCGCGTGGGACCCCTTGAACACCTTCCATCACAGCATGTCCATAGGACTCTGA	MTASVPPFTVGREDPRYIELSHSDNHRFVVEPEEFFLPATPDDVVASLQKAVTEGRGVACRSGGHCGQDFVGTPRRDLVLDLHNLHAIGPAADGAGVRVGSGATVDQVQKALFRRWNAALPLGACSAVGMGGLVAGGGYGPLSRQLGLVVDHLHAVEVAVVDESRTVRLVTARADDTGDLGELFWAHTGGGGGNFGVVTAYEFRSPEHLATEPVGLPRAAGRLHVQKVVFPWAMIDETSFVTVMRRFFEWHERHSEPGSPESSLFATFFVNHVSSGVLQLMVQQDADVDPEGEILARFVASLTEGTGVVGIPRGGVMSWLTGTRYMSQADCGDVMGARSASKSAYHRAAPTDEQLSVLHRHLHADHPGQASYVMFNSYGGEINRRGPSDAAVPQRDSVVKSSWFSAWQDAELDELHLGWLRGLYEEFFAGTGGVPVTGGRTDGCYINYPDADLLDPARNRSGEPWHHLYYKDNYARLRSAKRAWDPLNTFHHSMSIGL	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	154.66	gnl|BL_ORD_ID|1937|hsp_num:0	2014			282	504	polymyxin B
BGC0000226.1|Gilvocarcin_11 # 10616 # 11641 # -1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=CCCCCG;rbs_spacer=15bp;gc_cont=0.703	BGC0000226.1|Gilvocarcin_11 	10616	11641	-	Loose	400	31.9574	Erm(K)	22.22	3004643	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGCAGATCCTCGACCTCCTGATGGGAGGCTGGCGCGCCGGTGTCGTCAGCACGTTCGCGGAACTGGGCGTGGCCGACGGCCTGGCCGCCGGCGGGCTGACGCCCGCACAACTGGCGGTCCGGCTGGGGTTGGAGCACGACACCGCGGAGCGCTTCTTCCGCGCCGGCGCCTCCGTGGGGCTGCTGCGGAGGGGCGAGCACGACACGCTGGAGCTGACGGAGCTGGGCCGGGCCCTGGCCTCCGACGACGGCTCCATGCGCAACTTCGCGCGGTGGACGGGGTCGACGGCCGAACGCGCGACCTGGGCCCACCTGGCCACCGCGGTGCGCACCGGCCGCTCTCCCTTCGCCGCGATGCACGGTTCGGGCGTGTGGGAGTTCATGGAGTCGGATCCCGACACCGCGGCCGTCTTCAACTCGGCCATGACCGAACTGTCCAAGCGCGTCATCCAGCCCGTGATCGAGGCGTTCGACTTCTCCCGGTTCAGCAGTGTCACCGACGTGGGCGGGGGGAGGGGGGCGCTGCTGGCCGCCGTGCTCCGCAAGCACCCCGAGATGACCGGCGTCCTCTTCGACCAGCCGGACGTCGTGTCGCGGTCCCTGCCGGAGCTGTCGGACGCGGCGGTGGCCCACCGCGTCACGGTGAAGTCCGGCTCCTTCTTCGACGGCGTTCCGTCGGGCAGCGACCTGTTCATGATCTCCAACGTGCTGCACGACTGGGACGACGGCCGTTCCCGTCTCATCCTCAGGAACATCGCGGAGGCCATGCACGAGGGGGCGCACATCGCCGTCGTGGAGGCTGTGGCGGGCCTGGACGACACGGCGGACAAGGCGATCTCCCTCATGGACATGGACATGCTCCTCCTGTGCGAAGGCAAACAGCGCACCGTGGAGGAGTTCCGGCTCCTGATGGCCGAGGTCGGGATCGAGCTGGTCGGGGTCAGCCGCGCCGGACTCCAGTCCGTCGTCGAAGGAAGGAAGGTCTCGGGGGAGACCGGTACACCGGGCTCTCCCCGCAGCCGGTGA	MQILDLLMGGWRAGVVSTFAELGVADGLAAGGLTPAQLAVRLGLEHDTAERFFRAGASVGLLRRGEHDTLELTELGRALASDDGSMRNFARWTGSTAERATWAHLATAVRTGRSPFAAMHGSGVWEFMESDPDTAAVFNSAMTELSKRVIQPVIEAFDFSRFSSVTDVGGGRGALLAAVLRKHPEMTGVLFDQPDVVSRSLPELSDAAVAHRVTVKSGSFFDGVPSGSDLFMISNVLHDWDDGRSRLILRNIAEAMHEGAHIAVVEAVAGLDDTADKAISLMDMDMLLLCEGKQRTVEEFRLLMAEVGIELVGVSRAGLQSVVEGRKVSGETGTPGSPRSR	MTKKKHKYSNKKLSRGEPPNFSGQHLMHNKKLLQEIVDQAKVSKKDTVLELGAGKGALTTFLSERAKRVLAVEYDQTFIQVLNRKMAHAANTTIIHEDIMRIHLPKGEFVVVSNIPYSITTPIMKKLLSNPVSGFQRGVIVMEKGAAKRFTSPFIKNAYVLAWRMWFDLEYVKGISRECFSPPPKVDSAMVFISRKPDPIVPYKDRSAFFGLAEYALREPKAPADSLLRGIFTATQLKHVKRNAGIKHDVSIGALSERQWGVIFETMTQYVRRPLWPRPRKTTL	120.07	gnl|BL_ORD_ID|2122|hsp_num:0	3341			84	327	erythromycin
BGC0000226.1|Gilvocarcin_12 # 12076 # 13647 # -1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.695	BGC0000226.1|Gilvocarcin_12 	12076	13647	-	Loose	1050	163.696	facT	31.84	3001313	protein homolog model	n/a	n/a	elfamycin antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGTCGCTGGTGGTCGTGGACTTCACCATCGTCAACGTGGTGATGCCGCCGATCATCGACGACCTCGAGATCTCGGCCTTCGGCGCCCAGTGGATCCAGGAGTCCTACGCGATCATCCTGGCCGCTCTGCTGCTGGTGATGGGGCGTCTGTCGGACGTGGTGGGAGCACGCCGGCTGTTCCTCATCGGCACCGTGGTGTTCGGGCTGGCGAGCATCGCCGCCGCCCTGGCGCCCTCCGGGGAACTCCTGATCGCCAGCCGGTTCGCCCAGGGCGTCGGCGGCGCGATCATCATGCCGACCTCGCTCGCCCTGCTCAACATGTCCTTCCGGGGAGCCGACCGGGGCAAGGCCTTCGCCATCTGGGGGTCCACGATCGGTGCGGCCGCCGCGGTCGGCCCGCTCCTGGGCGGCTGGCTCGCCGAGTTCTCCTGGCGGTGGGCGTTCGGCATCAACATCTTCGTCGTGGTGCTGATCATCGCGGGCGTCATGAAGTTCCTGGACCAGTCCCCCGCGCAGCCGGGCAAGGTCGACGCCGTCGGCGGCGTGCTGTCGGTGCTGGGCCTCGGACTTCTCGCCTTCGCGCTGATCGAGGGCCGCAACTACGGCTGGTGGGACCCGCGCAAGAGCTTCGGTCCCTTCGGCGACCCGGTGGAGCTGTCGGTCATCCCGGTCGCCCTGGTCGTCTCCGTGGTGTGCCTGGGGCTGTTCCTGCAGCGCCAGGTCCGGCTCACCCGGGTGGACGGCACGGCGCCGCTGATGGACACCTCGCTGTTCGGCATCAAGTCCTTCAGCACGGGCAACATCGCGACGCTGATCATCGCGCTGGCGGAGTTCGGCATGCTCGCCGTTCTCCCCCTGTGGCTCCAGTACACGCTGGGGTACTCGGTGCTCCAGACCGGACTGATCGTCTTCGTCGTCGCGGTCGGCAGCTTCTTCGCGAGCGGTGCGAGCTTCGGCATGGCCGAGAACGTCGGCCCCATCGGGCTGGTGCGCATCGGCCTCGTCCTCGAGGCCGTCGGTCTGCTGATGTTCGGTCTGCTGGCCAGCAGCGACTCGCAGTGGTGGGTCATCGGCATCGCCCTCTTCCTGTACGGCATGGGAGTCGGGTTCGCTACGGCGCAGGTCACCAACGTCGTCCTGGCGGACGTGCCGCCGCGGCACGCCGGCCAGGGATCCGGCATCCAGAGCGCCGCACGCCAGCTCGGTTCCGCGCTCGGCATCGCGATTCTGACGTCGACCTTCTTCACGGCACTGGACTCCGACCTGTCCGACCGGCTCGTCGACCAGGGGACGCCCGCGCCGGAGGCGAACGAGCTGTCGTCGGCGGTCTCCGACAGCGCCGGCGCGATGATCTCCGGACTGAGTGAGAACCCGGACACGGCGGCCGCCGCCGACGCCGCCCGCGACGCCATGTCGTACGCGATCCAGATCAACGGCTACACCTGCGCCGCGCTGCTGGCGCTCGGGATGCTGGCGACCTTCCTCATCCCGCGGCCCAAGGGGGACGCCCAGCAGTGGGGAGGGGAGAACGCTCCCCGCGGGGCCGAGGAAGCCGACGTGGACGCGAAGTAG	MSLVVVDFTIVNVVMPPIIDDLEISAFGAQWIQESYAIILAALLLVMGRLSDVVGARRLFLIGTVVFGLASIAAALAPSGELLIASRFAQGVGGAIIMPTSLALLNMSFRGADRGKAFAIWGSTIGAAAAVGPLLGGWLAEFSWRWAFGINIFVVVLIIAGVMKFLDQSPAQPGKVDAVGGVLSVLGLGLLAFALIEGRNYGWWDPRKSFGPFGDPVELSVIPVALVVSVVCLGLFLQRQVRLTRVDGTAPLMDTSLFGIKSFSTGNIATLIIALAEFGMLAVLPLWLQYTLGYSVLQTGLIVFVVAVGSFFASGASFGMAENVGPIGLVRIGLVLEAVGLLMFGLLASSDSQWWVIGIALFLYGMGVGFATAQVTNVVLADVPPRHAGQGSGIQSAARQLGSALGIAILTSTFFTALDSDLSDRLVDQGTPAPEANELSSAVSDSAGAMISGLSENPDTAAAADAARDAMSYAIQINGYTCAALLALGMLATFLIPRPKGDAQQWGGENAPRGAEEADVDAK	MNKAGQAEKPAAAGPPATPETPEPDPKRWLALTVLLVATFMDLLDANIITVAIPSIQRDLGASTFAIQAMTAGYTLSFAVLLITGGRLGDIFGRKRMFLVGVGGFVLASAMCAAAPSTDLLVVARALQGLTAAVMVPQVLALIHVSFAPQEIGRVVSLYASMVGLAIVSGPLIGGALISWNPLDLGWRSIFVVNLPVGVLALVGAAKWMRESSSPHAKRLDIAGMLLIVLGLLLLMVPLTLGRELDWPVWSIVSLVAAAPVLVLFVVYERHKTAKDGSPLVTLSLFKVRAFGAGIGVQLLFSAIPAGFFLSWTLYLQAGLGWSALHTGLTAIPFSLCVPIVGGLAVRRLSPLYGRYCLLAGAVLMLAGILSYAWAADRFGTDITSWHAIPSMLLIGSGMGMLMPPLTALVLREVQPQEAGAASGIINATGQLGAALGVAVIGSLFFAALAGNAGPQAERVAPTVQSVSPRQASDLRDCATEALGQDDLAKVPDICSTLVQGADDGTRDTINGALGEIRAKTFVSTYSETLYWAAGGLVPVTALVLLLPHHRVRREEPAQ	93.56	gnl|BL_ORD_ID|1345|hsp_num:0	1469			126	1542	factumycin
BGC0000226.1|Gilvocarcin_14 # 14952 # 15962 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.701	BGC0000226.1|Gilvocarcin_14 	14952	15962	-	Loose	1200	36.1946	arnA	26.13	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGACCGCCACGAGGATCCTCGTCACCGGTGGTGCCGGCTTCATCGGCTCCCACTACGTCCGCACCCTGCTCGGCCCGCACGGGCCCGCCGGGGTCCGCATCACCGTGCTCGACAAACTGACCTATGCCGGCAACCCGGCCAACCTCGACCCGGTCCGTGCCCACCCCGGGTTCCGCCTCGTCCAGGGCGATGTCTGCGACGCCGCGGTCGTGGACCGGCTGGTCGCCGAGCACGACCAGATCGTGCACTTCGCCGCGGAGTCGCACGTGGACCGGTCGATCCTGGGGGGCGCCGAGTTCGTCCGCACGAACGTGGGCGGAACGCAGGTCCTGCTCGACGCGGCGCTGCGCCACCACGGACGCGGCCGCGGCGTCTTCGTCCAGGTCTCCACGGACGAGGTGTACGGCTCGATCCCCTACGGTTCGTGGCCGGAGACGCACCCGCTGTCACCCAGTTCGCCCTACGCGGCCTCGAAGGCCGCCGCCGACCTCGTCGCCCTCGCCCACCACCGCACCCACGGCCTCGACGTCCGGGTGACCCGCTGCTCCAACAACTACGGCCATCACCACTTCCCCGAGAAGCTGATCCCGCTGTTCATCACGCGCCTCCTCGAGGGCCGCACCGTCCCGCTGTACGGGGACGGGCTCAACGTCCGCGACTGGCTGCACATCGACGACCACGTCCAGGGCATCGAACTGGTCCGCACGAAGGGCAGACCCGGCGAGGTCTACAACATCGGCGGCGGCACCGAGCTCACCAACAGGGAACTGGTGTCACTGCTCCTGGAGGCGTGCGGGGCCGGCTGGGAGTCGGTGGAGTACGTCGCCGACCGCAAGGGACACGACAGGCGCTACTCGGTGGACTGCGCCAAGATCACCCTGGAGCTGGGCTACGAGCCCCGCAAGGATTTCGCCACCGGCCTCGCGGAGACCGTCTCCTGGTACCGGGAGAACCGGGACTGGTGGGAACCGCTGCGGCAGCGCGCCGAGCTGGGACAGGCGGTCCGCTGA	MTATRILVTGGAGFIGSHYVRTLLGPHGPAGVRITVLDKLTYAGNPANLDPVRAHPGFRLVQGDVCDAAVVDRLVAEHDQIVHFAAESHVDRSILGGAEFVRTNVGGTQVLLDAALRHHGRGRGVFVQVSTDEVYGSIPYGSWPETHPLSPSSPYAASKAAADLVALAHHRTHGLDVRVTRCSNNYGHHHFPEKLIPLFITRLLEGRTVPLYGDGLNVRDWLHIDDHVQGIELVRTKGRPGEVYNIGGGTELTNRELVSLLLEACGAGWESVEYVADRKGHDRRYSVDCAKITLELGYEPRKDFATGLAETVSWYRENRDWWEPLRQRAELGQAVR	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	50.76	gnl|BL_ORD_ID|1513|hsp_num:0	1643			951	1749	polymyxin B
BGC0000226.1|Gilvocarcin_15 # 15959 # 17095 # -1 # ID=1_15;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.689	BGC0000226.1|Gilvocarcin_15 	15959	17095	-	Loose	350	27.335	mfpA	45.95	3003035	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	TTGTTTCCAGACATCCGTGCGCTGCCGGGCCGATTGAGATGTTTCCCCGCCCGCCTAGACTGCGCCGCCATGAAGGCTCTCGTACTGTCCGGCGGGGCCGGAACCCGCCTGAGGCCCATCACCCATTCCTACGCCAAGCAGCTCGTCCCCGTAGCCAACAAGCCCGTGCTCTTCTACGGGTTGGAGGCGATCGCGGAGGCAGGCATCACCGAGGTCGGCATCGTCGTCGGGGACACGGCCGCCGAGATCCAGCAGGCGGTCGGCGACGGCTCCGCCTTCGGTCTGGACGTCACCTACATACGGCAGGCGGCGCCGCTCGGTCTCGCCCATGCCGTCCTGATCGCCCGGGAGTTCCTCGGCGACGACGACTTCGTCATGTACCTCGGAGACAACTTCATCGTGGGCGGTATCGCGGATCTCGTGGCCGGGTTCCGCGAGAGCCGGCCCGACACGCACATCCTCCTGACCAAGGTGGCCGACCCCAGCGCCTTCGGTGTCGTCGAACTCGACGACGACGGGAAGGCGGTGGCGCTGGAGGAGAAGCCGGCCGCTCCGCGCAGCGACCTGGCCCTGGTCGGCGTCTTCCTGTTCACCTCCGTGGTGCACGAGGCCGTCCGGGGGATCGAGCCGTCCGCACGCGGCGAGCTGGAGATCACCGACGCCCTGCAGTGGCTCATCGACCACGGGTACGACGTCCGCTCCACCACCATTTCCGGTTACTGGAAGGACACCGGGAACGTCATCGACATGCTGGAGGTCAACCGGGCCGTGCTGGAGGGCGCCAAGGGCCGGGTCGACGGCTATGTCGACGCGGACAGCGAGGTCATCGGCCAGGTCACGATCGAGGCGGGCGCCGAGATCCGCGGATCGCGGATCGTGGGGCCGGCCGTGATCGGCGCCAACACGCGGATCACCGGCTCCTACGTCGGCCCGTCCACGTCGATAGCGGCGGACTGCCGGATCGAGTCCAGCGAGATCGAGTTCTCCATCGTCCTCGCCGGGGCCACGGTCCAGGGGGTCCGCCGCGTGGAGAGTTCCCTGATCGGGCGGAACGTCGAGGTGACCCCCGCCGCCGGTGTGCCGGCGGCCCACCGGCTGGTCCTCGGGGACCACAGCGAGGTGCGTATCTCGTCATGA	MFPDIRALPGRLRCFPARLDCAAMKALVLSGGAGTRLRPITHSYAKQLVPVANKPVLFYGLEAIAEAGITEVGIVVGDTAAEIQQAVGDGSAFGLDVTYIRQAAPLGLAHAVLIAREFLGDDDFVMYLGDNFIVGGIADLVAGFRESRPDTHILLTKVADPSAFGVVELDDDGKAVALEEKPAAPRSDLALVGVFLFTSVVHEAVRGIEPSARGELEITDALQWLIDHGYDVRSTTISGYWKDTGNVIDMLEVNRAVLEGAKGRVDGYVDADSEVIGQVTIEAGAEIRGSRIVGPAVIGANTRITGSYVGPSTSIAADCRIESSEIEFSIVLAGATVQGVRRVESSLIGRNVEVTPAAGVPAAHRLVLGDHSEVRISS	MQQWVDCEFTGRDFRDEDLSRLHTERAMFSECDFSGVNLAESQHRGSAFRNCTFERTTLWHSTFAQCSMLGSVFVACRLRPLTLDDVDFTLAVLGGNDLRGLNLTGCRLRETSLVDTDLRKCVLRGADLSGARTTGARLDDADLRGATVDPVLWRTASLVGARVDVDQAVAFAAAHGLCLAGG	206.56	gnl|BL_ORD_ID|734|hsp_num:0	801			429	540	ciprofloxacin; levofloxacin; moxifloxacin; gatifloxacin; nalidixic acid; norfloxacin; sparfloxacin
BGC0000226.1|Gilvocarcin_16 # 17305 # 17844 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=CGCGCG;rbs_spacer=13bp;gc_cont=0.691	BGC0000226.1|Gilvocarcin_16 	17305	17844	+	Loose	900	26.1794	lsaD	26.15	3005121	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	lsa-type ABC-F protein	GTGATGGGCGAGGCGGAGTTCGAGCTGGTCGACCTGGCGGAGTACGGCCTCCCGTTGCTCGACGAGCCCGTGCCGGCGATGTTCGGCCAGTACCAGAAGGAGGAGACCCGGCGGTGGGCCGCCGCCATCGGCTCGTTCGACGGATTCGTCTTCGTCACGCCGGAGTACAACCACTCGGTGCCCGCCGCGCTGAAGAACGCCATCGACCACCTCTTCGCCGAGTGGACCGACAAGGCGGCCGGGTTCGTCAGCTACGGCGTGCACGGGGGAACCCGTGCCGTCGAGCACCTGCGGCTGGCCCTGGCCGAGGTGAAGGTGGCCGGGGTGCGCAGCCAGGTCGTCCTGTCGGTGTTCAACGACTTCGACTACACGGGATGCGACATGACGGACCCGACGGCCATGGGCCGGTTCACGCCGGGACCGCAGCAGGAGCAGACGGTGAACACGATGCTGGACGAGGTCGTCGCCTGGTCGACGGCGCTCAAGCCGCTGCGTACTGCTGCGACCGCTGAGGCGGACGGCCGGGCCGTGTCGGTGTGA	MMGEAEFELVDLAEYGLPLLDEPVPAMFGQYQKEETRRWAAAIGSFDGFVFVTPEYNHSVPAALKNAIDHLFAEWTDKAAGFVSYGVHGGTRAVEHLRLALAEVKVAGVRSQVVLSVFNDFDYTGCDMTDPTAMGRFTPGPQQEQTVNTMLDEVVAWSTALKPLRTAATAEADGRAVSV	MSNIKINNLTFGYTDQLIFDNVNINIDDQWKLGLVGRNGRGKTTLLKILLGEVDVHLEIKTNKSFVYFPQTINDKDQLTLFVLQELADFEQWELERELTLMGVDLDTLWRPFNSLSGGEQTKTLLALLFLDEHNYPLIDEPTNHLDKASREKVAAYLSEKKGYILISHDRNFLNKTTDHTLAIERADLQVYAGNFAIYEEEKRLRDLTEKAQDDKLRKEIGRLKQTAREKEAWSRNLEATKSRKKRGFDSETKRVDKGFIGRKAANMMQKSKNLEKRMKEDIADKELLLKNWEEVPGLEMSVLESHQKRLLTVENLAAGFEDFLFEPVSFTLEQGQVLALTGENGRGKSSLMKVLTGEFTGRYVGTFELAHNLVISEVRQLADNRGFLNEFAKKENLELELFLNNLRKLGVERKVFEQKIENMSQGQQRKVELARALSQPAHIYLWDEPLNYLDVFNQEQIIQMIKRSKPSMLVIEHDQYFVDQVADAQIELIKSSV	36.02	gnl|BL_ORD_ID|4773|hsp_num:0	3847			378	546	lincomycin; clindamycin; virginiamycin M1; tiamulin
BGC0000226.1|Gilvocarcin_17 # 17873 # 18118 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.699	BGC0000226.1|Gilvocarcin_17 	17873	18118	+	Loose	200	23.0978	vanX gene in vanA cluster	35.29	3002949	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanX; glycopeptide resistance gene cluster	GTGAACGTGCTGGTCACGGCCCCTCGTGCGTACGCTACGAGGGCCGTGACCAGCACGTTCGCCTGTACGGGCGAGCGTGGCCGCCACGCCGCGGGTGGGCGGCGGCAGCACGCCGGCCGGACCGATCGCCGAGTGGCTTGTTACGTGCCCGGGGCGACGGCGCCGGAGGGGGACGCGCCGAAAAAAACCGGTCAGTCGAGTTCCCCTTCGATAACACGGATATCCCCCCGTCCTCACTTCGGGTGA	MNVLVTAPRAYATRAVTSTFACTGERGRHAAGGRRQHAGRTDRRVACYVPGATAPEGDAPKKTGQSSSPSITRISPRPHFG	MEIGFTFLDEIVHGVRWDAKYATWDNFTGKPVDGYEVNRIVGTYELAESLLKAKELAATQGYGLLLWDGYRPKRAVNCFMQWAAQPENNLTKESYYPNIDRTEMISKGYVASKSSHSRGSAIDLTLYRLDTGELVPMGSRFDFMDERSHHAANGISCNEAQNRRRLRSIMENSGFEAYSLEWWHYVLRDEPYPNSYFDFPVK	40.10	gnl|BL_ORD_ID|4670|hsp_num:0	217			210	303	vancomycin; teicoplanin
BGC0000226.1|Gilvocarcin_18 # 18115 # 19659 # 1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=CCCCC;rbs_spacer=14bp;gc_cont=0.704	BGC0000226.1|Gilvocarcin_18 	18115	19659	+	Loose	600	258.07	Streptomyces venezuelae rox	37.32	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGACCTACTTCGGCCGTGCGACTCCGAGCATCGTGAGCGGCATGACGTTGCACGCCGCAGAAGCCATACCGTCACACGTACCGGTTCTCGTCGTGGGAGCCGGCCCGACAGGTCTCATGCTCGGCGCCGAGCTGGCGCTCCACGGCAGCCGGCCGCTGGTGATCGACGCGCTGCCGAGCCCGAGCGGACAGTCCCGGGCCCTGGGCTTCACGGTGAGGACGCTGGAGATCTTCAAGCAGCGCGGCATCCTGGGCCGTTTCCAGGGACTCGCCCCGGTGCCCGGAGTCCATTTCGCCGGCCTCAGCATCAAGGGCGATCACCTCTCCAGCTCGATGCGCCCGGCCAACCAGTACCCGCAGTCCAAGACCGAACAGGTCCTCGCCGCCTGGGCCGAGGAGCTGGGAGTACCGGTGCGGCGCCCGTGGACGCTGACGTCCATGGAGCCCACTGGCACCGGGTACCGCTGCGTGCTCAGCGGCCCGGCCGGGCAGCAGACCGTCGACGCCGACTACGTGGTCGGCTGCGACGGAGCGGGGAGCTTCGTCCGCGAGGCGATCGGCATGCCGACCAAGCGCACTCCCCCATCCGTACAGATGCTCCTCGGTGATCTGCGCGGATGCGGTCTGCCCGACGAACCCTTCGGGGTCAAGCACGAAAAGGGCATGGTCATGTCCGCACCGCTGGGCGACGGGACGGAACGCGTCATCGTCTGTGACTTCACCCAGCCGATGCGGCCGCAGGGCACTCCCGTCACGCACGACGAGATCAAGGCCGCCTACGAGCAGGTCGTCGGCAGCCCCCTGGCGGACGGCGAATGTCTCTGGGCGAGCTCGTTCTCGGACGCGTCCTCCCTCGTGGAGTCCTACCGGTCCGGTCGTGCGCTGCTCGTCGGCGACACGGCGCACACCCATCTCCCCGCCGGCGGGCAGGGCATGAACGTCTCGATACAGGACGCGGTGAACGTCGGCTGGAAGCTCGCGCTGGTGAGCCAGGGCCGCGCGCCGGACACCCTGCTGGACACCTACCACGCCGAGCGGTACCCGGTCGGCAGGGAACTGCTGCTCAACACCGCCGCCCAGGGCCAGGTCTTCCTGCGCGGCCCGGAAGTGGACCCGCTGCGCGAGGTCCTGCGGCGACTGCTGAACATCCGGGAGGTGTCCGTCCTGCTGGCCGACGGAGTCAGCGGACTGGACATCCGCTACGACATGGGCCTCCCGGAAGCACCGCCACCCACGGGTGAACGGCTGCCGCCGGACGTGTTCCACGTCGTCGGGACCGGCGGCGACGCCGTCGAGGAGTTGCGGCACGGCGCCGCTCTGCTGATCGTCCCGTCCCCCGACAGCCCGGCGTCCTCGCTGGTCGCTCCGTGGCGGGACCAGGTGCGCGTCGTGCACGCGCGCCCCACGGACCCGGACTGGGGCGGGGAGCCGGCCGCGTCGTCGCACTGGTTCGTACGACCGGACGGACACATCGCGTGGGCGGGCACCGAATTCAGCGAGTTGAGCGCCTCACTGAGCCGCTGGCTCGGTCAGCCCGCCGCGTAA	MTYFGRATPSIVSGMTLHAAEAIPSHVPVLVVGAGPTGLMLGAELALHGSRPLVIDALPSPSGQSRALGFTVRTLEIFKQRGILGRFQGLAPVPGVHFAGLSIKGDHLSSSMRPANQYPQSKTEQVLAAWAEELGVPVRRPWTLTSMEPTGTGYRCVLSGPAGQQTVDADYVVGCDGAGSFVREAIGMPTKRTPPSVQMLLGDLRGCGLPDEPFGVKHEKGMVMSAPLGDGTERVIVCDFTQPMRPQGTPVTHDEIKAAYEQVVGSPLADGECLWASSFSDASSLVESYRSGRALLVGDTAHTHLPAGGQGMNVSIQDAVNVGWKLALVSQGRAPDTLLDTYHAERYPVGRELLLNTAAQGQVFLRGPEVDPLREVLRRLLNIREVSVLLADGVSGLDIRYDMGLPEAPPPTGERLPPDVFHVVGTGGDAVEELRHGAALLIVPSPDSPASSLVAPWRDQVRVVHARPTDPDWGGEPAASSHWFVRPDGHIAWAGTEFSELSASLSRWLGQPAA	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	107.98	gnl|BL_ORD_ID|4833|hsp_num:0	5820			9	1425	rifampin; rifaximin; rifapentine
BGC0000226.1|Gilvocarcin_19 # 19678 # 20004 # 1 # ID=1_19;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.664	BGC0000226.1|Gilvocarcin_19 	19678	20004	+	Loose	650	22.7126	mexP	34.88	3003698	protein homolog model	n/a	n/a	macrolide antibiotic; carbapenem; tetracycline antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGTTCAGCTCTCTCATCGTCGCCCGGATGGACACCGGCCACGCCGAAGCGGTGGCCGACGTCTTCGCCGGCTTCGACGCCACCGACATGCCCGCGCGGATGGGCACGCGGCGCCGCGAACTCTTCCGCTACCGCGGCCTCTACTTCCACCTCCAGGACTTCGAGACCCCCGACGGGACCGAAGCGGTCGAGGCGGCCAAGTCCGACCCGCGGTTCATCCGGGTGAGCAACGACCTCAGGCCCTACATCGAGGCCTACGCCCCGGACTGGCAATCACCGAAGGACGCCATGGCAGAGCGCTTCTATCACTGGAGTTCGAAACGATGA	MFSSLIVARMDTGHAEAVADVFAGFDATDMPARMGTRRRELFRYRGLYFHLQDFETPDGTEAVEAAKSDPRFIRVSNDLRPYIEAYAPDWQSPKDAMAERFYHWSSKR	MNLRHFIRITATLGVAALIAGCGESAPPGAASAPPSVPVAEVVVRPVTPYAEFTGSLTAVEQVELRPRVAGYIQDVTVPEGRLVEKGQQLFLIDPRVFKAAQDAARARLREAEAAALLARTEHERAELLYARKVVARERLDSAIASRNASKAQVDAARAALDAAQLDLGFTRVTAPIGGRVGHIQVTEGNYVTNGVTALTSIVSVDPLYVYFDVDERTYLQALAPTRGREGEQAPRVKVALLTDESYGRSSRLDFLANAADRGTGTVRVRAVVDNPDGQLTPGLFAKVRLETGKPRAQVLVADHSIGTDQGRRYVLVVDEGNKTQYRPVELGPMVDGLRVVRQGLQPGERIVVKGLVRPDMQITPRLAEIDGTPVDLSKTVGAAQ	28.05	gnl|BL_ORD_ID|2009|hsp_num:0	2211			546	675	erythromycin; acriflavine; tetracycline; imipenem; trimethoprim; chloramphenicol; thiamphenicol; kitasamycin; rokitamycin
BGC0000226.1|Gilvocarcin_20 # 20001 # 21260 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.699	BGC0000226.1|Gilvocarcin_20 	20001	21260	+	Loose	750	198.364	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	36.28	3003463	protein variant model	R121K, F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGAGCCGCAGGGTCTTCATCACCGGGGTCGGTGTCGTCGCGCCGGGAGCCGTCGGACGTGACCCCTTCTGGGAGCTGCTGACCCAAGGGCGCACGGCCACCCGCCGGCTCAGCCTCTGCGACCCGGAGCCCTTCCGGTCCCAGGTGGCCGCGGAGGCCGACTTCGACGCCGAGGCGGCGGGGCTGTCGGAGCGGCAGTCCGCGGAACTGGACCGGGCGGCGCAGTTCGCCCTGGTCGCCGCCCGTGAAGCGGTCGAGGACGCGGCATGGTCCGAGACATGTCCTCCCGAACGCGCCGGAGTGATCGTGGGTTCGGCCGTCGGAGCCACGACCAAGCTCGAGGAGGTCTACCGGCAGCTCAGCCGTGACGGCTCCCTCTGGGACGTGGCCCCCGACTCCCCCGCCGAGCTGTACTCGTACTTCGTGCCCAGCTCGTTCGCCTCCGGCATCGCACACGACCTCGGCGTCACGGGGCAGAGCGGCGTCGTGTCGACCGGGTGCACCTCCGGGATCGACTCCGTCGGCAACGCCTGGGAACTGATCCAGAGCGGCATCCTGGACTCCGCCGTCTGCGGTGCCACCGACGCCCCCATCTCGCCCATCACCGTCGCCTGCTTCGACACGATCAAGGCGACATCGACGTACAACGACACCCCGGAGAGCGCCTCACGGCCGTTCGACGCCACACGGGGCGGCTTCGTCCTCGGCGAGGGCAGCGCGATGTTCGTCCTCGAATCGGAGGAATCCGTCCACCGTCGCGGCGCACGCGTCTACGGCGAGATCCGCGGCTACGCGAGCCGCTGCAACGCCTACCACATGACCGGTCTCAAGGCCGACGGACGCGAGCTGGCGGAGGCCGTCGTCTCCGCTCTCGGCCAGGCAGGCGTGGACCCGGGCCGGCTCGACTACGTCAACGCCCACGGCAGCGGCACGAAGCAGAACGACCGCCACGAGACCGCCGCGCTGAAGTCGTCCCTCGGACCCGCCGCCCACGACGTGCCGATCAGTTCGATCAAGTCGATGATCGGCCATTCGCTGGGCGCCATCGGGTCGTTGGAGATCGCCGCCTGCGCCCTGGCGCTGCGGGACGACGTGATCCCGCCGACGGCCAATCTCACCCGGCCGGATCCGGAACTCGATCTGGACTACGTGCCGGTCCACGCGCGCAAGCAGCCGACCAACAGCGTGCTCACGACCGGAAGCGGCTTCGGTGGGTTTCAGAGCGCCATGGTTCTCACGGACCCGGAGCATCACTCATGA	MSRRVFITGVGVVAPGAVGRDPFWELLTQGRTATRRLSLCDPEPFRSQVAAEADFDAEAAGLSERQSAELDRAAQFALVAAREAVEDAAWSETCPPERAGVIVGSAVGATTKLEEVYRQLSRDGSLWDVAPDSPAELYSYFVPSSFASGIAHDLGVTGQSGVVSTGCTSGIDSVGNAWELIQSGILDSAVCGATDAPISPITVACFDTIKATSTYNDTPESASRPFDATRGGFVLGEGSAMFVLESEESVHRRGARVYGEIRGYASRCNAYHMTGLKADGRELAEAVVSALGQAGVDPGRLDYVNAHGSGTKQNDRHETAALKSSLGPAAHDVPISSIKSMIGHSLGAIGSLEIAACALALRDDVIPPTANLTRPDPELDLDYVPVHARKQPTNSVLTTGSGFGGFQSAMVLTDPEHHS	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	100.72	gnl|BL_ORD_ID|1968|hsp_num:0	1943			285	1239	isoniazid
BGC0000226.1|Gilvocarcin_21 # 21257 # 22432 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.718	BGC0000226.1|Gilvocarcin_21 	21257	22432	+	Loose	500	25.409	OXA-96	23.81	3001631	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACCGCACACATCACCGGCATCGACATCGTCTCCCCGCTGGGCCTGTCCCGCGAGGAACACTGGAAGGCCCTCCTCGACGGATGCAGCGGTCTGAGGGCGACGCAGTCGTTCGACTCCAGCAGGTACGACAACCCCATCAGCGGGGAGGTGCCCCACTTCGCCCCGGAGGGCCTGCCCAAGCGGCTGCTGCCGGCCACCGACCGGATGACCCAGATGTCGCTGGTCGCCGCGGCGGGGGCGTTCGACGACAGCGGTGTCGACACGAGCCGGGTCGACCCCCTCGGAGTCGGTGTCATGACGGCGTCCACCGCGGGGGGTTACGCGTTCGGGCAGAAGGAGCTGCAGAACCTGTGGTCCAAGGGGCCCAGGTACGTCAGCACCCATCAGTCCTACGCCTGGTTCTACGCGGTCAACACCGGTCAGATCTCCATCCGGCACGGCTGCCAGGGCCACAGCGGAGTGATCGTCGCGGACGACGCCGGCGGGCTCGACGCGATCTCCTTCGCCGCCCGCCGTCTGGCGCGCGGCAACCGCGTCATGCTCACCGGGTCGGTGGACAGCACGATGTGTCCCTGGGGGCGGGTCGCGCACACCTCGACCGGCATGCTCTCGGCATCCACCGACGCGCGGGCCGCGTACCTTCCGTTCGACGCACGAGCCAACGGGTGGGTCAACGGCGAAGGCGGCGCGCACCTCGTGCTGCAGACCCACAGTGACGGCCGCTACGCGGCGGTGCTCGGTCACGGTGCGACCATGGACGATCCCCGCGCCGCCCCGGGCACGGGCCTCGTCCGGGCGATCCACCTCGCGCTCGGCGCGGCGCGGCTGCGCCCCGGCGACATCAGTGTGGTGTTCGCCGACGCGGCCGGCACCCGGGAGGCGGACACCGCCGAGGCCGCCGCCCTCGCCGAGGTCTTCGGGCCGGATTCCGTCCCCGTCACCGCGCCCAAGGCGGCGACCGGCCGGATGGGCTGCGGGACGGCCGCACTCGACGTCGCGACGGCGGTGCTCGCCCTCCGCGACCAGACGATTCCCCCCACCGTCAACGTCCAGGCCGACGCGTCCCTGGGGGTCAACCTGTGCAGCGTCGCCACACACCACCCCCTCACCAACGTCCTGGTCCTGGCCCGGGGCGTCGGTGGGTTCAACTCGGCCCTGATCGTCGGGAAATGA	MTAHITGIDIVSPLGLSREEHWKALLDGCSGLRATQSFDSSRYDNPISGEVPHFAPEGLPKRLLPATDRMTQMSLVAAAGAFDDSGVDTSRVDPLGVGVMTASTAGGYAFGQKELQNLWSKGPRYVSTHQSYAWFYAVNTGQISIRHGCQGHSGVIVADDAGGLDAISFAARRLARGNRVMLTGSVDSTMCPWGRVAHTSTGMLSASTDARAAYLPFDARANGWVNGEGGAHLVLQTHSDGRYAAVLGHGATMDDPRAAPGTGLVRAIHLALGAARLRPGDISVVFADAAGTREADTAEAAALAEVFGPDSVPVTAPKAATGRMGCGTAALDVATAVLALRDQTIPPTVNVQADASLGVNLCSVATHHPLTNVLVLARGVGGFNSALIVGK	MKLLKILSLVCLSISIGACAEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTYDGQNIKKYGTHLDRAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKDFTLGEAMQASTVPVYQELARRIGPSLMQSELQRIGYGNMQMGTEVDQFWLKGPLTITPIQEVKFVYDLAQGQLPFKPEVQQQVKEMLYVERRGENRLYAKSGWGMAVDPQVGWYVGFVEKADGQVVAFALNMQMKAGDDIALRKQLSLDVLDKLGVFHYL	139.64	gnl|BL_ORD_ID|552|hsp_num:0	605			444	606	cloxacillin; oxacillin; cefalotin
BGC0000226.1|Gilvocarcin_22 # 22448 # 22717 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.670	BGC0000226.1|Gilvocarcin_22 	22448	22717	+	Loose	550	22.3274	Nocardia farcinica rox	45.0	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGTCCGCACGCGTCACCATGGACGATCTCAGGCGAGCCCTCGAGGAGGGCTCCGGTGTCGACGAGGGCGTCGATCTTGACACCGACCTCGAAACCATGGCGTTCTCCGAGCTGGGGTACGACTCCCTGGCGGTGCTGGAGACCGGCCTGCGCCTCGGCCGCGAGAACGACATCGAGCTCGACGACTCGGTGTTCGCCGACCTCGACACGCCTCAGCAGATGCTGGACGCGGTCAACGATGCCCTCGCGCGTCAGGCGGCGGCATCGTGA	MSARVTMDDLRRALEEGSGVDEGVDLDTDLETMAFSELGYDSLAVLETGLRLGRENDIELDDSVFADLDTPQQMLDAVNDALARQAAAS	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	18.82	gnl|BL_ORD_ID|4834|hsp_num:0	5821			684	744	rifampin
BGC0000226.1|Gilvocarcin_23 # 22714 # 23493 # 1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=CGCGCG;rbs_spacer=15bp;gc_cont=0.688	BGC0000226.1|Gilvocarcin_23 	22714	23493	+	Loose	450	35.8094	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	24.56	3004045	protein variant model	F203A	n/a	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	GTGACCTCTCCCCGTCATGCCCTGGTCACCGGCGGTTCCAGCGGCATAGGAAAGTCCGTCGCACGGCGCCTGGCCTCGGCCGGCCACACCGTCACGATCTGCGGTCGTGACTCCGAAAGGCTCCAGCAGGCCGCCAAGGAACTGTCGGAGCAGGGTGCACCCGTCACCTCGCTGATCGCCGACGTCAGCAAGCCCCGCCAGGTGGGCGATCTGGTCCGCGAGGCCGTGGAGACGAACGGTCCCCTCGGGATCCTCGTCAACAACGCGGGCAGGAACGGAGGCGGCCGGACCGCGGAGCTGAGCGACGAGCTGTGGCGGGAGGTACTGAGCACCAACCTCGACAGCGTTTTCTACGTCACGCGGGAGGTGCTGGCCCGTGGCGGCATCGGCGAGGTGGACCACGCCCGGATCATCAACATCGCCTCCACCGCGGGGAAGCAGGGAGTTCTGCTGGCCGCCCCGTACTCCGCCTCCAAGCACGGTGTCGTCGGCTTCACCAAGGCGGTGGGCAAGGAGCTGGCCCCTCAGGGGATCACCGTGAACGCCGTCTGCCCGGGCTACGTGGAGACCCCGATGGCCTCACGGGTCCGGCAGGCCTACGCAGACGCCTGGGAGACCACGGAGGCCGAGGTGCTGTCCGCCTTCGAGGCGAAGATCCCGCTCGGCCGGTACAGCACGCCCGACGAGGTCGCCTCGCTGGTCGAGTACCTCACGACCGAAGGAGCCGCCTCGATCACGGCTCAGGCGTTCAACGTGTGCGGCGGCCTCGGCAACTTCTAG	MTSPRHALVTGGSSGIGKSVARRLASAGHTVTICGRDSERLQQAAKELSEQGAPVTSLIADVSKPRQVGDLVREAVETNGPLGILVNNAGRNGGGRTAELSDELWREVLSTNLDSVFYVTREVLARGGIGEVDHARIINIASTAGKQGVLLAAPYSASKHGVVGFTKAVGKELAPQGITVNAVCPGYVETPMASRVRQAYADAWETTEAEVLSAFEAKIPLGRYSTPDEVASLVEYLTTEGAASITAQAFNVCGGLGNF	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	98.85	gnl|BL_ORD_ID|4712|hsp_num:0	2666			438	753	triclosan
BGC0000226.1|Gilvocarcin_24 # 23497 # 24456 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.693	BGC0000226.1|Gilvocarcin_24 	23497	24456	+	Loose	700	25.409	tet(X4)	27.87	3004720	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGATTCACATGGCCGATCCGGCTCGCACAGACCTGCACTCCGCCACGATCACCGGCAGCGCCGACGCGGTGTACCGCCGTCTGGAGGACGTCGGGCAGTGGTCCCAGATGTTCGAACCGACCATCCACGGCGCGGAACTGGCCCGGGACGGGAACAGGCAGACGATCCAGCTGTGGGCCACCGCCAACGGAGAACCCAAGGCCTGGGTCTCCGAGCGTGAGCTCGACCCCGTCGCGCGCACCATCCGCTTCGCGCAGACCGTCACCTCCTCGCCCGTCGCCGAGATGTCCGGCGCGTGGCAGGTGCTGCCCCTGTCCGAGGACACCTGCCGGGTCGAACTCACGCACACCTACCGTGCGGAGAACGACTCGGCGGAGTCGCTCACATGGATCGCCCGAGCCGTGGAGACCAACAGCACGAAGGAGCTCTCGGCGCTCAAGTTCGCCTGCGAACGGGACGCCGACAGCGAGGCCAGTCCCTTCACCTTCACCGATGCGGTGGACACCACGGTCGACCCCGTCCTGCTGTTCTCGTTCCTGGACCGCGGTGAGCTGTGGGCGGGACGCCTGGAGCACGTCGCCGAGGCCGAGATGAGGGAGTTCTCCGACGGCCTGCAGTTCCTCCGGATGCGGACGCGCACCCCGGACGGTGACACGCACGTCACCGAGTCCTACCGGGTGTCGCAGAGCCCGGCCCGGCTGCTGTACAAGCAGGTGACGCTGCCCGCGCTGCTGTCGCTGCACACCGGCGAGTGGACCATCACCCCGGCCGGGGAGAGCTGGCGGGTCACGTCGAAGCACACCGTGGCGATCGATCCCGACGCGGTGCACAAGGTCCTCGGTGCCGACGCGACGGTCTCGGACGCCAAGCGGCTCGCCCGGCGCAACCTGGGCAACAACAGCCTGCGGACCCTCGAAGCAGCGGTCCGGTGGGCCGGCACCGCCGTGTCGCAGAGGTGA	MIHMADPARTDLHSATITGSADAVYRRLEDVGQWSQMFEPTIHGAELARDGNRQTIQLWATANGEPKAWVSERELDPVARTIRFAQTVTSSPVAEMSGAWQVLPLSEDTCRVELTHTYRAENDSAESLTWIARAVETNSTKELSALKFACERDADSEASPFTFTDAVDTTVDPVLLFSFLDRGELWAGRLEHVAEAEMREFSDGLQFLRMRTRTPDGDTHVTESYRVSQSPARLLYKQVTLPALLSLHTGEWTITPAGESWRVTSKHTVAIDPDAVHKVLGADATVSDAKRLARRNLGNNSLRTLEAAVRWAGTAVSQR	MSNKEKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHHPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIRVTSSFVGLATRIFPLGKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFIYGKEAQEESTQNEIEMFKPDFTFQQLLNV	82.86	gnl|BL_ORD_ID|2277|hsp_num:0	3402			861	1041	tigecycline; tetracycline
BGC0000226.1|Gilvocarcin_25 # 24453 # 25820 # 1 # ID=1_25;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.742	BGC0000226.1|Gilvocarcin_25 	24453	25820	+	Loose	550	129.798	Nocardia farcinica rox	32.2	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGAGTGGGGACATGACGGAGCCCGAGACCTCGGACGTTCTCGTCGTCGGCGCCGGGCCCAGCGGACTGCTCCTGGCCGGGATCCTCGCCGGGGCGGGTGCGCGGGTCACGGTGCTGGAGGCGCGGGACGCGCCCAGCCCGCAGACCCGCGCCTCCACCTTGCACGCCCGTGCCAGGGAGATCCTCGACCACCACGGAGTGGAGTTCTCCCCGGAGCTGCCCTGGAGTGCCCACGGACACTACGGCGGCCTGCGCGTGGACCTCTCCCGGGTCGACTCCGGGCGGGCCGGTGTCTGGAAGTGCCCCCAGCCGGAACTGGTACGGACGCTGACCGGCTGGGCCCGCGGGCACGGCGCGCGGCTGCTCCACGGGGAGCACGTGGAGTCCGTCCGCGAGCAGGGCGGGCGCTGTCTGGTGCGTACCCGGGCCGGCACCACGTTCAGCGGGACCCTGCTGGTCGCGGCGGACGGCCGGCGGAGCACGGTGCGGTCGCTGCTGGGCATCGGGTGCGGGGGTGCGCCGGCCACGCGCGTACTGGTGCAGGCCGATGTCCACGGCGACGGGCTGGCGGGGCGGCGCTTCGAGCGACACGGGCGGTACACCGTGACCGCCGCACCGATCAGCCCCGGGATCACCCGGGTGATGCTGCACGATCCGCGCTGGCCCGCGGGCGAGGAACGCACGCTGGAGGACCTCCGTAGAGCCTGGAAGGAGTCCACCGGCGAGACCCTGCCGGCCGAGCCGTCGTGGTCACGGACCTTCAGCGACGACACGACAGTGGCACACCCGCTGGTCAAGGGCCGTGTCGTGCTGTGCGGCGACGCCGCCCACCCCTTCGTCCCCATCGGCGGCCAGGCGCTGAACACGTCGTTGATGGACGCCGAGGCGCTGGGCTGGCGGGTCCTGGGGTATCTGGACGACGGGGACCGGCAAGGCCTCCTCGACTACCAGGACGAGCGGTTCTCGTGGCTGACCGTTCTCGCGGGGAGACTGCGCGCCCAGGCACGTCTGCTGTTCGACACCGACGCGGCGGCCACGGAACGCAAGGCGCTGGTCGCCGCGAGACTGGCCGGGGACGCGGACTACCGGCGCAGGATCGCCGACGCCCTGGCCGGTGTCGACGTGTGCTACCTGACGCCCGGCGGCGCGGTCCGCCGGCGTCTGTCCCCGGCCCGGCTCCGGGAGACCGGAGTGAACCCCGGCGCCCGCCGCGTGCAGCGGGCGCTCGTCCCCGACGACGGAACGCGCACGGACGCCTGGATCCGTCCCGATCACCACTGGTACCCGGTGGCCCGCGACGGGGCCCGGCAGGACTGGGACGACGCGGTGCGCCTCCACGACGACTTGGAACCCGAGGTGACGCGGTGA	MSGDMTEPETSDVLVVGAGPSGLLLAGILAGAGARVTVLEARDAPSPQTRASTLHARAREILDHHGVEFSPELPWSAHGHYGGLRVDLSRVDSGRAGVWKCPQPELVRTLTGWARGHGARLLHGEHVESVREQGGRCLVRTRAGTTFSGTLLVAADGRRSTVRSLLGIGCGGAPATRVLVQADVHGDGLAGRRFERHGRYTVTAAPISPGITRVMLHDPRWPAGEERTLEDLRRAWKESTGETLPAEPSWSRTFSDDTTVAHPLVKGRVVLCGDAAHPFVPIGGQALNTSLMDAEALGWRVLGYLDDGDRQGLLDYQDERFSWLTVLAGRLRAQARLLFDTDAAATERKALVAARLAGDADYRRRIADALAGVDVCYLTPGGAVRRRLSPARLRETGVNPGARRVQRALVPDDGTRTDAWIRPDHHWYPVARDGARQDWDDAVRLHDDLEPEVTR	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	96.19	gnl|BL_ORD_ID|4834|hsp_num:0	5821			6	1134	rifampin
BGC0000226.1|Gilvocarcin_26 # 25817 # 26749 # 1 # ID=1_26;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.695	BGC0000226.1|Gilvocarcin_26 	25817	26749	+	Loose	1150	25.7942	blaR1	32.61	3000217	protein homolog model	n/a	n/a	penam	antibiotic inactivation	BlaZ beta-lactamase	GTGAGAGCGTTCCTGTTCCCCGGTCAGGGGACCCAGAAGATCGGCATGGGCACCTACCTGCGAGAACGGTACCCCCACCTGATCGCGCCGTTGTGGCGGGAGGCGGACGACGTCCTGGGTTTCCCCCTCACCCGCCTCTGCGAGGAAGGCCCCGGCGAGAAGCTCCGCCACATGCCGGTCACCCAGCCCGCCGTCTTCCTGTGCAGTTACGCCGCGCTCGTCGCCGCGCAGGCGAACGGCGCGGAGCCGGACGTCATCGCGGGCCACAGTCTGGGCGAGTACTCGGCGCTGGCGGCGGCCGGCGTCCTCACCTGGCAGGAGGTCCTTCAGCTCGTCCACCGCCGCGGTCAGCTCATGGCGGAGGTGCAGCACAAGGTGGACGGGAAGATGGCGGCCGTCATCGGTCTCGCCATCGGGCAGGTCGAGGAGATCTGCGAGCAGGTGCGGTCCGAGACCGGTGAGGTGGTCGAGGTGGCCAACCACAACGAGCCCCTCCAGGTCGTCGTCTCCGGCCAGTGCGCTGCCATAGACCTCCTGGTCCAGCGCGTCGCGACGGCGACCGACGTCCGCACGTCCGTCCTGAGGATCGGTGGCCCGGCCCACTCCAGTCTCATGGGCAGCGTCGCGGGGGACTTCGTGGAGTACCTCCGGCGCTTCGACTTCTGCACGCCCAAGACGATGCTGATCTCCGGGTCGACCGCCGAGCCCTACGCGAGTGCGGAGGAGATCAGGCACCAGCTCGGCAGGCAGCTGGTGCACCGGGTGCGGTGGGTGGACGTGATGGCGCAGCTCGAGAGGCTGGGGGTCGCACAGACCTGGGAGCTGGGGCCGGGCAAGGTCCTCTCGGGATTCGTACAGCGGTCGCTGCCTCAGGTGCGGACGTACCGCGCGAATGATCTGCCGTCCTTCCTGGCCGGCGTGACGGGCTGGTGA	MRAFLFPGQGTQKIGMGTYLRERYPHLIAPLWREADDVLGFPLTRLCEEGPGEKLRHMPVTQPAVFLCSYAALVAAQANGAEPDVIAGHSLGEYSALAAAGVLTWQEVLQLVHRRGQLMAEVQHKVDGKMAAVIGLAIGQVEEICEQVRSETGEVVEVANHNEPLQVVVSGQCAAIDLLVQRVATATDVRTSVLRIGGPAHSSLMGSVAGDFVEYLRRFDFCTPKTMLISGSTAEPYASAEEIRHQLGRQLVHRVRWVDVMAQLERLGVAQTWELGPGKVLSGFVQRSLPQVRTYRANDLPSFLAGVTGW	MTLPHILLSLVLITATILVIFFVRAVFYKQLSAKWRYHLWFLLITVLTLPFIPIHLLTGLSFFDQGRQQITPSAQKRFGFADQNEQWMVDFGTSVSRFDDTFIHAVFVSIWIGGMIFFLLLTLYHYAKLQRLVKAASRIQNQKVENAFSDCMAELQITNKLTNLESPAIQTPMTFGWLKTYILLPKNIELYLSDDEIRHVLLHELHHYKSKHIKVNYIFVVYQIVYWFHPLVWKAFKEMRLDRELACDTEVLLTLGQREYKAYGQTIMRFLERNSRFLYLTNPLHSSKKAFKNTKSYNIAFFYWRVKSGAQLKKPWVVFAGLTRFCIAQFPFLTATAVSTERYQFDESQAVVEDYSTYFAGNEGSFVLYSLTSDQFEIYNKEKSVRRVSPNSSYKIYTALMALELGVIGRDDSWLEWDGVEYEDEAWNSGQDLKSAMSQSVTWYFQELDERIKQRNIQSFVNQLDYGNKDLSGGLNHYWLESSLKISPVEQVELLHSFYTNQLDFKEEHVQFVKEVMKLEENQKGTLYGKTGTGIVNGHAINGWFIGFVETETDTYFFATNIQQKIMHMEARLLKSLYPFCQAKEFID	52.72	gnl|BL_ORD_ID|1900|hsp_num:0	2063			534	672	
BGC0000226.1|Gilvocarcin_27 # 26754 # 27785 # 1 # ID=1_27;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.709	BGC0000226.1|Gilvocarcin_27 	26754	27785	+	Loose	600	28.8758	RSA2-1	33.33	3006981	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	RSA2 beta-lactamase	GTGAAGCACGCAGTGCCGCATCAGGCAACCGGCGCCGCTCCCGACGGAGGGGGGTCCGCGCCCCGGTCCCTCGTGCTGATGCTCCCCGGCCAGGGGTCGCAGTTCGCTGCCATGGGAGTCCCGCTCTACGAGTCCGACGCCCGGTTCAGGAAGGCGCTCGACGACTTCTTCGACGCGTTCGGCACCGGTGCCGAGCGGCTCCGGCGCGAGTGGCTGCACGGTTCGGCCCAGGGCATCGAACGTGGGTCCTTCGCGCAGCCGATGCTGTTCGGCCTCGACTACGCGGCGGGCGCGGTGTGGCTGGAGGAGCTCAAGGGTGTCGACGTGACGCTGGTCGGTCACAGCGTGGGCGAGCTGGCGGCGGCCACCCTCGCGGGGGCCTTCGACCTCGAGCTGGCGGGGGCACTCCTGGCCGAGCGGGCCCGGCTCCTCGACGCCGCCCCCCGGGGAGGGATGATCGCGTGCCGCGCGACGGAGGAGTCGCTGCGGGAGCATCTCGACGCCCTGGGCGGACGCGCCGTCATCGCGGCGGAGAACGCGGACAACCAGTGCGTCGTGAGCTGTGCCGAGGAAGACCTCCCGGACACGATGCGGTACCTCGGCTCGCACGGTGTGACGTGCCTGCGCGTCGCCTCGACCGAACCGTTCCACTCCCCCCTCCTCGCCCCCGCCGCCGCCCGGTTCGAGGAGTTCCTGGCCCGGCGCGGTCATCGTCTGTCCACGACGGAACTGCCCATGGTCTCGGCCTACTCGGCGCGGAGGATCAGCGGCCGGGAGATCATGCCCGCCTCGTTCTGGACGCGTCAGATGGCTGAGAAGGTGCGTTTCTGGGAGGCGCTCCGCCACAACTTCGACTCCGGTCCCCGCACGTTCGTGGAAATCGGCCCAGGGACCGTCCTCTCCCTGGCCGCACGTCGGCTGCCGTCCGTACGGGCCCGGCGTTCCACGGTGATCTCCACGATGCCGCGTCATCGGCCCCACCCGGAGCACTGGGAATCGGCCATACATGAGGTCGCCGAGGAATTCTGTTGA	MKHAVPHQATGAAPDGGGSAPRSLVLMLPGQGSQFAAMGVPLYESDARFRKALDDFFDAFGTGAERLRREWLHGSAQGIERGSFAQPMLFGLDYAAGAVWLEELKGVDVTLVGHSVGELAAATLAGAFDLELAGALLAERARLLDAAPRGGMIACRATEESLREHLDALGGRAVIAAENADNQCVVSCAEEDLPDTMRYLGSHGVTCLRVASTEPFHSPLLAPAAARFEEFLARRGHRLSTTELPMVSAYSARRISGREIMPASFWTRQMAEKVRFWEALRHNFDSGPRTFVEIGPGTVLSLAARRLPSVRARRSTVISTMPRHRPHPEHWESAIHEVAEEFC	MANTTICRLCAVSQAGLSLGETLIKGQVMSFLRSAAIFAAVLLPLSAHAADLDQTIEALENRLDARIGVAIHDTGTGKVWGHREDERFLMNSTIKVPLCAAVLSRSDVDLSEELPVRAEDILEYAPVTEQHVGGTMTVADLCFATIDQSDNTAANLLFGRLGGPESLTTFLRSIGDDLTRSDRLEPDLNIWSAGDPRDTTTPAAMVRTLEAMLTGDALTATAREQLADWMRPGGVTGALMRPSVPHNWDVADKSGSGSNTRNLIAMLTPPDGAPIFVSLSISEAEVDFATRNAALVELSAAVVRSLHAQN	110.65	gnl|BL_ORD_ID|4568|hsp_num:0	5638			717	879	
BGC0000226.1|Gilvocarcin_28 # 27823 # 27933 # 1 # ID=1_28;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.568	BGC0000226.1|Gilvocarcin_28 	27823	27933	+	Loose	350	21.1718	DfrA34	40.91	3005346	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	GTGTCCCCCGAGTTCCCGGGAGGCACCCATGGCCTTGTCGGTGAAATGTTCAACCAAATGAACCACCTCTCGAGGGCGCCCCGGATCAAAGATGTTCACCGATTTGCATAG	MSPEFPGGTHGLVGEMFNQMNHLSRAPRIKDVHRFA	MITACVAIDSDGGFGAQGTLPWAIPEEFAFYQEHVRGGICIIGGRSFNDLVHLSLSPKGGLYKKCLLRTTPHIVVSSSHELVYDPSIMALIEADRRHLDLYFVNTVDAAVKLAKGLGGMHANKDIHFIGGKRIYDAGLDYCDEVYTSILPAVYLNCDTFFPVEKLSRMFTPELYKTIPNQVHADIPVIKWTRKRA	18.46	gnl|BL_ORD_ID|3052|hsp_num:0	4078			108	174	trimethoprim
BGC0000226.1|Gilvocarcin_31 # 28537 # 30507 # 1 # ID=1_31;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.652	BGC0000226.1|Gilvocarcin_31 	28537	30507	+	Loose	400	29.6462	vanR gene in vanO cluster	28.17	3002930	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	TTGACCGGGCGCAAGTACCGCACCGTGGTTTCGTATCTCGCTCTTCAACCCGAGTATTCGGTGGCGATAGAGGACCTCGTCCGAGCCGCTTGGAGCGACAAGCGCCCGTCCAGCGCGCACCACCAGGTCCGTAAGATGGTCTCCGCACTCCGGACCAGCCTGGACCAGGACTGGGACCTGGTGGCGACGTCCCAGGACGGCTACATGCTGAAGTTGCCGCCCAAGCAGTCCGACGTATCCGAATTCTGCCGCCTCTTCGACCAGGTGATGTCGGGTCCCCTGACGAGCGACGACGACCTGTCGGCCGCGTATTCGGCGCTGGCGCTCTGGCGCGGACGCCCTTGCGAAGGGTCCGAGCCCCATGGGCAGGAGCGCCGGATCTCTCAATTGGTGGAACAGCACCGCGTCCTCTTGAACAAGACCGTTCAGGGATTCGGCGACAGGGGCAGGTCCGATGAACTCGCCTCGATACTGCACGTCGCATCGAAGATTCACGGACAGCCGGTCACCGCTCGCTCCGGTGTCGCCGTTCCCGCGCCCGCTGTTTCGTACGCGGGCACGACACAAGTCCCCGAACCTTCGGGGTCGACCACCCCTCCCCCACGCCCCGGCTCCCCCGTCGGTCCGCGCTGCCTGCCACGGGATCTGCAGGACTTCGGCGGCCGCGAACGCGAAATCAATGAGCTGCAGAAACTGTTGACCGCGGAAGGACCCCACCCACAGTTGGTGGCGACCGTTCACGGAATGAGCGGCGTGGGTAAAACCGCCGTCGCCGTCCGCCTGGCGCACAGACTAGCCCATCACTATCCGGACGGCCAGCTCTTTGTATCCCTGGACGGCTTTTCTTCGGCCTCCACCGCCACCGTGTCGAATGCGCTGGGAATACTCCTCAGACAGAAAGGCCTGGCGGACGAGGACATTTCACCTTCGGAAGACGGCCGCCTCGCACAATGGCGGACCATCACCGCCGGACAGAAGCTGCTCGTCGTGCTCGACGACGTGTGCGACATCGAGCAAGTAGAACCCCTCATCCCGCCCTCGAGCGAAAGCGCCTGCATCATCACGTCGCGCATCATCCTCAATGGCATCGACGGCGCTCATCACATCTCACTCGAAGTACCGGACGAGGACGAATGTCTGGAGATACTCAGTTGCATGATCGGCAGACGCTTCGACGACGAGGAGACGAAGGACGCCCGCGCGCTGATCCAGCAGTGCGCCAATCTGCCGCTGGCACTCCGTCTCGCCGCCGCCCGGATATCGACGCGCGACTTCCTGAACCTCCGGGAACTCAGTGAGCAACTGTCGTCCTCGGCTTCCATCTTCAGTGAACTGGAAGTTCCCGGCCGTAGTCTGGTCGGCCGGCTCATGACGTCCTTCACGTGCCTGGAGGACTTCGATCACGACCGGTACCTCCGATTATCGCTGCTCCCCTGCCCCGAGATCGATGAAACGTCGGTCGCGGCCGTGCTGGGCGTATCCACCGACTGGGCACGGCGTGCCTGCAGGCGCTTCGCAGACCGCGCGTTGCTGCAACGCACACGATGCGGTACGTACCGGATGCACCCGCTGCTGCTGCAGGCGGCACAGCTGGAAGCGCAGAAGACCATCCCGTTCGAGGAGCAACGCCGGCTCGTCCGCGCCGCTTTCCTCCATTACAAGGCGTCGAACGGCCTCGTGGGAGCCAGCCGCATCAGCCCTTCCCGGGTTCCTGACGGACACGTGGTACTGAGGACCCTCACGCAGTCCGCGAAGCTGGCCGCGCGGCTCGGCCTCCAGGAGGAGTTGGCCGATCTGTACACCGCCTGGAAGGAACTGCTCCCCCTCGTGCTGGACCGCCGGCAGCAGGAGGCGGTCGGGCGACGCGTACTCGCCGTTTCACAGCACCTGGACCGGCCCGCGTGCGAGGGAGCACCCCACCGGAGGCGTCCGCGGCAGGCACGGGACATGCTGCCCGAGGGGCAGCGGTGA	MTGRKYRTVVSYLALQPEYSVAIEDLVRAAWSDKRPSSAHHQVRKMVSALRTSLDQDWDLVATSQDGYMLKLPPKQSDVSEFCRLFDQVMSGPLTSDDDLSAAYSALALWRGRPCEGSEPHGQERRISQLVEQHRVLLNKTVQGFGDRGRSDELASILHVASKIHGQPVTARSGVAVPAPAVSYAGTTQVPEPSGSTTPPPRPGSPVGPRCLPRDLQDFGGREREINELQKLLTAEGPHPQLVATVHGMSGVGKTAVAVRLAHRLAHHYPDGQLFVSLDGFSSASTATVSNALGILLRQKGLADEDISPSEDGRLAQWRTITAGQKLLVVLDDVCDIEQVEPLIPPSSESACIITSRIILNGIDGAHHISLEVPDEDECLEILSCMIGRRFDDEETKDARALIQQCANLPLALRLAAARISTRDFLNLRELSEQLSSSASIFSELEVPGRSLVGRLMTSFTCLEDFDHDRYLRLSLLPCPEIDETSVAAVLGVSTDWARRACRRFADRALLQRTRCGTYRMHPLLLQAAQLEAQKTIPFEEQRRLVRAAFLHYKASNGLVGASRISPSRVPDGHVVLRTLTQSAKLAARLGLQEELADLYTAWKELLPLVLDRRQQEAVGRRVLAVSQHLDRPACEGAPHRRRPRQARDMLPEGQR	MASMRVLVVEDERFMAEAIRDGLRLEAIAADIAGDGDTALDLLGVNAYDIAVLDRDIPGPSGDEIAQRIVASGGGIPILMLTAADRMDDKASGFELGADDYLTKPFELQELVLRLRALDRRRAHSRPPVREIAGLQLDPFRREVYRDGRYVALTRKQFAVLEVLVAAEGGVISAEELLERAWDENADPFTNAVRITVSTLRKRLGEPWLIATVPGVGYRIDTEPDARGGGDGG	281.55	gnl|BL_ORD_ID|4742|hsp_num:0	1689			462	672	vancomycin
BGC0000226.1|Gilvocarcin_34 # 31903 # 32112 # -1 # ID=1_34;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.748	BGC0000226.1|Gilvocarcin_34 	31903	32112	-	Loose	600	22.7126	EstT	28.95	3007459	protein homolog model	n/a	n/a	macrolide antibiotic; glycylcycline; tetracycline antibiotic	antibiotic inactivation	macrolide esterase	CCCCTCGTCGTCGTCGGCACCACCCGGGACCCGGCCACCCCGTACCGCTGGGCCGAGGGTCTGGCCGGCCAGCTCGCCACGGCCCGCCTCCTCACCTACGACGGCGACGGCCACACCCCGTACGGCCGCGGCAGCGCCTGCGTCGACTCCGCCATCAACACCTACCTCCTCGACGGCACCCCGCCCGCCGACGGCACACGCTGCTCGTAG	PLVVVGTTRDPATPYRWAEGLAGQLATARLLTYDGDGHTPYGRGSACVDSAINTYLLDGTPPADGTRCS	MKKKLLWILILGLIIISCKQRKTEMKEKIIKTNGIELCTESFGNKKNPAILLVAGATVSMLYWDTEFCQQLSEKGFFVIRYDNRDVGKSTNYEPGSTPYDIVDLTNDAISILDGYKIDKAHFVGISLGGLISQIASIKFADRVNSLTLMSSGPWGDSDPTIPEMDTSILDFHSKAGTVNWTNEDSVVNYLIQGAELMSGKKQFDKQRSEKLIRAEFNRANNYISMFNHAASQGGGGEEYWNRLNEIKQPTLIIHGTDDKIWHYKNAGFLLEKIKGSNLITLEGTGHELHVDDWKSIIDGIEKHIND	22.55	gnl|BL_ORD_ID|4956|hsp_num:0	5948			744	858	tigecycline
